Comparative Pharmacokinetics of Epoetin Alfa in Cancer Subjects Receiving Cyclic Chemotherapy and in Healthy Subjects After Subcutaneous Administration of Epoetin Alfa 150 IU/kg 3 Times Weekly or 40,000 IU Per Week for 6 Weeks

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/029/30/03

Funding

  • R W Johnson Pharmaceutical Research Institute: $79,955.00